Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients (Q33343335)

26 July 2017

title

Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients (English)

1 reference

26 July 2017

1 reference

Hemant Kulkarni

1

0 references

author name string

Paul N Goldwater

series ordinal

2

1 reference

26 July 2017

Anne Martin

series ordinal

3

1 reference

26 July 2017

Karl A Bettelheim

series ordinal

4

1 reference

26 July 2017

publication date

1 July 2002

1 reference

Comparative Immunology, Microbiology & Infectious Diseases

26 July 2017

published in

1 reference

26 July 2017

volume

25

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

249-268

1 reference

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Escherichia coli 'O' group serology of a haemolytic uraemic syndrome (HUS) epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Detection of serum antibodies to the lipopolysaccharide of Escherichia coli O103 in patients with hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Serum antibodies to verotoxin-producing Escherichia coli (VTEC) strains in patients with haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Indirect hemagglutination assay for antibodies to Escherichia coli lipopolysaccharides O157, O111 and O26 in patients with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Haemolytic-uraemic syndrome outbreak caused by Escherichia coli O111:H-: clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Serum antibodies to secreted proteins in patients infected with Escherichia coli O157 and other VTEC.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Sporadic case of hemolytic uremic syndrome associated with verotoxin producing Escherichia coli O2:K1:H7

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Serological identification of infection by verocytotoxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

An outbreak of hemolytic uremic syndrome due to Escherichia coli O157:H7: or was it?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Immune response to Escherichia coli O157:H7 in hemolytic uremic syndrome following salmonellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

New perspectives on the role of Escherichia coli O157:H7 and other enterohaemorrhagic E. coli serotypes in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shiga-like toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Strains of Escherichia coli belonging to serogroups O157 and O55 express lipopolysaccharides that are structurally distinct and do not share common epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2802%2900011-5

7 January 2021

10.1016/S0147-9571(02)00011-5

Identifiers

DOI

1 reference

26 July 2017

1 reference